H. de Groot

Two distinct effects of recombinant human tumor necrosis factor-alpha on osteoclast development and subsequent resorption of mineralized matrix.

C. Löwik, G. van der Pluijm, G. Pluijm, 1991, Endocrinology.

Integrins and osteoclastic resorption in three bone organ cultures: Differential sensitivity to synthetic arg‐gly‐asp peptides during osteoclast formation

C. Löwik, G. van der Pluijm, S. Papapoulos, 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

In vitro and in vivo endochondral bone formation models allow identification of anti-angiogenic compounds.

C. Löwik, A. Baxter, G. van der Pluijm, 2003, The American journal of pathology.

Disodium 1‐hydroxy‐3‐(1‐pyrrolidinyl)‐propylidene‐1,1‐bisphosphonate (EB‐1053) is a potent inhibitor of bone resorption in vitro and in vivo

L. Binderup, C. Löwik, G. van der Pluijm, 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Modulation of PTH‐stimulated osteoclastic resorption by bisphosphonates in fetal mouse bone explants

G. van der Pluijm, S. Papapoulos, M. J. Alblas, 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.